News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Natco Pharma Limited Seeks 'Compulsory License' For Copy Of Pfizer Inc. (PFE) Drug



1/5/2011 6:54:38 AM

Dow Jones -- Natco Pharma Ltd. (524816.BY) said Wednesday it has informed Pfizer Inc. (PFE) that it wants to make and sell a low-cost generic version of the U.S. company's maraviroc for treating the HIV infection under a so-called "compulsory license."

Read at Wall Street Journal
Read at Pharmalot
Read at News Release
Read at Money Control


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES